scispace - formally typeset
V

V. F. Khokhryakov

Researcher at University of Utah

Publications -  42
Citations -  1267

V. F. Khokhryakov is an academic researcher from University of Utah. The author has contributed to research in topics: Population & Lung cancer. The author has an hindex of 21, co-authored 42 publications receiving 1228 citations.

Papers
More filters
Journal ArticleDOI

Mayak Worker Study: An Improved Biokinetic Model for Reconstructing Doses from Internally Deposited Plutonium

TL;DR: The systemic biokinetic model for plutonium currently recommended by the International Commission on Radiological Protection (ICRP) has been modified to reflect recently developed data and facilitate interpretation of case-specific information.
Journal ArticleDOI

Mayak worker dosimetry study : An overview

TL;DR: The updated dosimetry database, “Doses-2005,” represents a significant improvement in the determination of absorbed organ dose from external radiation and plutonium intake for the original cohort of 18,831 Mayak workers.
Journal ArticleDOI

Liver Cancers in Mayak Workers

TL;DR: Comparisons with Russian liver cancer incidence rates indicate excess risk, especially among those with detectable plutonium body burdens and among female workers in the plutonium plant, and within the Mayak worker cohort, which evaluate the role of plutonium body burden with adjustment for cumulative external dose.
Journal ArticleDOI

Bone cancers in Mayak workers.

TL;DR: Koshurnikova et al. as mentioned in this paper evaluated bone cancer mortality risks in 11,000 workers who started working at the “Mayak” Production Association in 1948-1958 and who were exposed to both internally deposited plutonium and external γ radiation.
Journal ArticleDOI

Mayak Worker Dosimetry System 2008 (MWDS-2008): assessment of internal dose from measurement results of plutonium activity in urine.

TL;DR: The modified Mayak Worker Dosimetry System-2008 more correctly describes plutonium biokinetics and metabolism in pulmonary lymph nodes and provides two sets of doses estimates: one based on bioassay data and the other based on autopsy data, where available.